Kalvista Return On Capital Employed from 2010 to 2025

KALV Stock  USD 8.77  0.10  1.13%   
Kalvista Pharmaceuticals Return On Capital Employed yearly trend continues to be fairly stable with very little volatility. Return On Capital Employed is likely to outpace its year average in 2025. During the period from 2010 to 2025, Kalvista Pharmaceuticals Return On Capital Employed regression line of quarterly data had r-squared of  0.14 and coefficient of variation of  255.83. View All Fundamentals
 
Return On Capital Employed  
First Reported
2010-12-31
Previous Quarter
18.0155902
Current Value
18.92
Quarterly Volatility
7.61525806
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 985.3 K, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors.
For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.

Latest Kalvista Pharmaceuticals' Return On Capital Employed Growth Pattern

Below is the plot of the Return On Capital Employed of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Return On Capital Employed historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Return On Capital Employed10 Years Trend
Slightly volatile
   Return On Capital Employed   
       Timeline  

Kalvista Return On Capital Employed Regression Statistics

Arithmetic Mean2.98
Coefficient Of Variation255.83
Mean Deviation5.75
Median(0.49)
Standard Deviation7.62
Sample Variance57.99
Range19.7674
R-Value0.38
Mean Square Error53.32
R-Squared0.14
Significance0.15
Slope0.60
Total Sum of Squares869.88

Kalvista Return On Capital Employed History

2025 18.92
2022 -0.66
2021 -0.5
2020 -0.22
2019 -0.48
2018 -0.3
2017 -0.49

About Kalvista Pharmaceuticals Financial Statements

Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Return On Capital Employed, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Capital Employed 18.02  18.92 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kalvista Stock Analysis

When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.